In RCC (786-0 and A489 lines), sorafenib activated autophagy, as evidenced by p62/SQSTM1 degradation, Beclin 1/autophagy protein 5 (ATG-5) upregulation, and LC3I/II conversion [162]. Here, SQSTM1 is linked to renal cell carcinoma.